FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair
Radiotherapy Dosing in Intracranial Ependymoma Using the National Cancer Database
Integrating Molecular Analyses with the 2021 WHO Classification for a More Precise Diagnosis of Adult Pilocytic Astrocytomas
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy
Altered Amino Acid Metabolism in Glioma: In vivo MR-spectroscopic Detection of Alanine as a Potential Biomarker of Poor Survival in Glioma Patients
Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors
Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastasis via the TGF-β/Smad signal pathway
The CCL2-CCR4 Axis Promotes Regulatory T Cell Trafficking to Canine Glioma Tissues
Stereotactic Radiosurgery for Brain Metastases from Human Epidermal Receptor 2 Positive Breast Cancer: An International, Multi-center Study
Biological effective dose as a predictor of local tumor control in stereotactic radiosurgery treated parasellar meningioma patients